Introduction
Hepatitis B and D are severe global health challenges, often leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma. While antiviral drugs can suppress viral replication, they don’t repair existing liver damage. Stem cell therapy represents a revolutionary treatment option, leveraging the regenerative and immune-modulating properties of stem cells to combat these conditions effectively.
Features
- Advanced Cellular Repair: Mesenchymal stem cells (MSCs) differentiate into hepatocyte-like cells to regenerate liver tissues.
- Reduction of Liver Inflammation: Cytokines released by stem cells help lower inflammation levels.
- Versatility: Suitable for both early-stage and advanced liver damage caused by HBV and HDV.
- Combination Potential: Enhances the efficacy of ongoing antiviral treatments.
Benefits
- Improved Liver Health: Restores liver function and structure by regenerating damaged tissues.
- Reduced Complications: Minimizes the risk of cirrhosis and liver cancer progression.
- Enhanced Antiviral Defense: Boosts the immune system’s response to viral infections.
- Minimally Disruptive: Requires no major surgery, leading to quicker recovery times.
Solutions
- Management of Persistent Infections: Targets long-standing liver damage caused by HBV and HDV.
- Addressing Treatment Resistance: Offers an alternative for patients unresponsive to antiviral drugs.
- Cirrhosis Prevention: Repairs early-stage fibrosis to prevent irreversible damage.
- Support for Liver Transplants: Reduces the need for transplantation by regenerating liver tissues.